Reducing the Risk of Pneumococcal Infection in Cancer Patients

Online Continuing Education Activity
for Physicians and Nurses

1.0 Hour Category 2A, AOA
1.0 AMA PRA Category 1 Credit™
1.0 CNE Contact Hour

Overview, Goal and Objectives
In the United States, the majority of chemotherapy and radiation therapy for cancer is provided in an outpatient setting. Both the disease for which they are being treated and the treatments themselves causes these patients to be more vulnerable to pneumococcal pneumonia due to a suppressed immune system. In patients being treated for cancer, a bacterial infection caused by Streptococcus pneumonia can cause a significant morbidity, prolonged hospitalization and increase mortality.

Patients with cancer, especially those 65 and older, who are undergoing or scheduled to undergo chemotherapy or radiation therapy should be repeatedly asked about their vaccination status and educated about their increased risk of pneumococcal infection and potential consequences, complications, prolonged hospitalization and even death. These questions and recommendations should be standard practice in every community –based oncology office.

The purpose of this activity is to reduce the risk of invasive pneumococcal infection in patients who are candidates for radiation and chemotherapy. The goal of this activity is to equip health care professionals with information related to current vaccination and patient assessment recommendations to facilitate vaccination status ascertainment and patient education.

Upon completion of this activity, attendees will have received information that should allow them to…

  • Employ processes to repeatedly ascertain a patient’s vaccination status who is considering or receiving chemo or radiation therapy.
  • Convey the relative risks of community-acquired infection for cancer patients , clearly describing the potential consequences of developing an invasive pneumococcal disease to patients diagnosed with cancer
  • Apply the most current ACIP guidelines when developing a treatment plan for patients with cancer.
  • Identify new opportunities during normal clinical operations to incorporate vaccination status ascertainment, which can lead to improved patient care.

Target Audience
This activity has been carefully designed to meet identified educational needs of physicians, nurses and other health professionals who care for patients for whom chemotherapy or radiation therapy is recommended or prescribed.

Presenter
Dr. DeanAsad Dean, M.D., specializes in medical oncology and hematology at Texas Oncology in Fort Worth, Texas. He is board certified in medical oncology, internal medicine and hematology.

Dr. Dean graduated Cum Laude with a Bachelor of Science in Biology from the University of Texas-Arlington. Dr. Dean received his medical degree from the University of Texas Southwestern Medical School in Dallas in 1997 and completed his internship and residency at the State University of New York Health Science Center in Syracuse. In 2003, Dr. Dean finished his fellowship in Hematology/Oncology at the University of Texas Southwestern Medical Center.

Dr. Dean is a member of the American Society of Clinical Oncology and the Tarrant County Medical Society. He was recognized by the Fort Worth Business Press as a Healthcare Hero of 2009 and as a “Top Doc” in Fort Worth, Texas magazine in 2009, 2010 and 2011. In 2003 he was appointed to the faculty of UT Southwestern Medical Center as Assistant Professor in the division of Hematology/Oncology.

Disclosures
Dr. Dean has disclosed that during the past 12 months, he has served as a speaker for Alexion and Prometheus Labs.

For a complete listing of disclosures for planning committee members and content developers, please CLICK HERE.

Hardware and Software Requirements

  • PC or Mac computer
  • High-speed Internet Connection (dial-up is NOT recommended)
  • Adobe Flash software
  • Adobe Reader software
  • Speakers
  • Printer (for certificate and handouts)

Off-Label Product Use
No off-label product uses are discussed during this activity.

Commercial Support
This activity is supported by an educational grant from Pfizer Medical Education Group. Great care has been exercised to endure the content is fair, balanced, and clinically accurate.

Accreditation and Credit
Physician Accreditation Statements
The University of North Texas Health Science Center at Fort Worth is accredited by the American Osteopathic Association to award continuing medical education to physicians.

The University of North Texas Health Science Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians.

Physician Accreditation Statements
The University of North Texas Health Science Center has re-quested that the AOA Council on Continuing Medical Education approve this program for 1.0 hour of AOA Category 2A CME credit. Approval is currently pending.

The University of North Texas Health Science Center at Fort Worth designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CNE Contact Hours
The University of North Texas Health Science Center is an approved provider of continuing nursing education by the Texas Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

This activity provides 1.0 contact hour for the nurse.

Non-Endorsement of Products Statement & Reporting of Perceived Bias

How to Receive Credit (Criteria for Successful Completion)
To receive a certificate of completion, participants are required to register and take the pre-test, participate in the entire activity, score 70% on the post-test, and complete evaluation at the end of the activity. A certificate will be available immediately (see FAQ below video player window in the activity).

Register Now